These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 27393319)

  • 1. [Not Available].
    Bandrant M; Bagheri H; Cuzin L; Sommet A; Bassoua V; Guitton E; Bonnet E; Garipuy D; Lucas F; Aquilina C; Montastruc JL; Massip P
    Therapie; 2006; 61(2):171-6. PubMed ID: 27393319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of antiretroviral drugs-induced adverse effects].
    Baudrant M; Bagheri H; Cuzin L; Sommet A; Bassoua V; Guitton E; Bonnet E; Garipuy D; Lucas F; Aquilina C; Montastruc JL; Massip P
    Therapie; 2006; 61(2):171-6. PubMed ID: 16886711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)].
    Pochard L; Hauviller L; Cuzin L; Eyvrard F; Sommet A; Montastruc JL; Bagheri H
    Therapie; 2014; 69(2):149-55. PubMed ID: 24926633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions: trends in a tertiary care hospital.
    Rehan HS; Chopra D; Sah RK; Mishra R
    Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.
    Remesh A; Balan A; Gnanadurai A
    J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase.
    Berhe DF; Juhlin K; Star K; Beyene KG; Dheda M; Haaijer-Ruskamp FM; Taxis K; Mol PG
    Trop Med Int Health; 2015 Jun; 20(6):797-806. PubMed ID: 25704305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006.
    Lapeyre-Mestre M; Grolleau S; Montastruc JL;
    Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
    Sánchez I; Amador C; Plaza JC; Correa G; Amador R
    Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventability of adverse effects in a medical emergency service].
    Olivier P; Boulbès O; Tubery M; Carles P; Montastruc JL; Lapeyre-Mestre M
    Therapie; 2001; 56(3):275-8. PubMed ID: 11482315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.